Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Lacaze

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Frontiers in Public Health|June 28, 2019
Editorial: Public Health GenomicsPaul Lacaze, Gareth Baynam
Frontiers in Public Health|March 3, 2018
Regulation of Internet-based Genetic Testing: Challenges for Australia and Other JurisdictionsJane Tiller, Paul Lacaze
Neurology|October 14, 2022
Common Genetic Variants and Early Onset Stroke: Clues but No AnswersJennifer Juhl Majersik, Paul Lacaze
European Heart Journal|April 9, 2026
Aspirin for elevated lipoprotein(a) in primary prevention: evidence mountingPaul Lacaze, Stephen J Nicholls
Public Health Genomics|September 25, 2019
Healthcare System-Funded Preventive Genomic Screening: Challenges for Australia and Other Single-Payer SystemsPaul Lacaze, Jane Tiller, Ingrid Winship
Frontiers in Public Health|January 12, 2018
Should Australia Ban the Use of Genetic Test Results in Life Insurance?Jane Tiller, Margaret Otlowski, Paul Lacaze
Genetic Testing and Molecular Biomarkers|September 7, 2017
Penetrance and the Healthy ElderlyPaul Lacaze, Ingrid Winship, John McNeil
Journal of Bioethical Inquiry|November 15, 2017
The Dangers of Direct-to-Consumer Genetic Testing for Alzheimer's Disease : Comment on "Personal Genomic Testing, Genetic Inheritance, and Uncertainty"Paul Lacaze, Jane Tiller, Joanne Ryan
Public Health Research & Practice|December 12, 2022
The Australian moratorium on genetics and life insurance: evaluating policy compared to Parliamentary recommendations regarding genetic discriminationJane Tiller, Paul Lacaze, Margaret Otlowski
Nature Reviews. Genetics|January 13, 2023
Prioritizing the detection of rare pathogenic variants in population screeningPaul Lacaze, Ranjit Manchanda, Robert C Green
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Frontiers in Public Health|June 28, 2019
Editorial: Public Health GenomicsPaul Lacaze, Gareth Baynam
Frontiers in Public Health|March 3, 2018
Regulation of Internet-based Genetic Testing: Challenges for Australia and Other JurisdictionsJane Tiller, Paul Lacaze
Neurology|October 14, 2022
Common Genetic Variants and Early Onset Stroke: Clues but No AnswersJennifer Juhl Majersik, Paul Lacaze
European Heart Journal|April 9, 2026
Aspirin for elevated lipoprotein(a) in primary prevention: evidence mountingPaul Lacaze, Stephen J Nicholls
Public Health Genomics|September 25, 2019
Healthcare System-Funded Preventive Genomic Screening: Challenges for Australia and Other Single-Payer SystemsPaul Lacaze, Jane Tiller, Ingrid Winship
Frontiers in Public Health|January 12, 2018
Should Australia Ban the Use of Genetic Test Results in Life Insurance?Jane Tiller, Margaret Otlowski, Paul Lacaze
Genetic Testing and Molecular Biomarkers|September 7, 2017
Penetrance and the Healthy ElderlyPaul Lacaze, Ingrid Winship, John McNeil
Journal of Bioethical Inquiry|November 15, 2017
The Dangers of Direct-to-Consumer Genetic Testing for Alzheimer's Disease : Comment on "Personal Genomic Testing, Genetic Inheritance, and Uncertainty"Paul Lacaze, Jane Tiller, Joanne Ryan
Public Health Research & Practice|December 12, 2022
The Australian moratorium on genetics and life insurance: evaluating policy compared to Parliamentary recommendations regarding genetic discriminationJane Tiller, Paul Lacaze, Margaret Otlowski
Nature Reviews. Genetics|January 13, 2023
Prioritizing the detection of rare pathogenic variants in population screeningPaul Lacaze, Ranjit Manchanda, Robert C Green
Pageof 15